{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:21:57Z","timestamp":1771460517796,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5970-0","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T14:03:34Z","timestamp":1564409014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines"],"prefix":"10.1186","volume":"19","author":[{"given":"Hendrik","family":"Dapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kilian","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Peeken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Borm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"5970_CR1","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299:1914\u201321.","journal-title":"JAMA"},{"key":"5970_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 2013;14:516\u201324.","journal-title":"Lancet Oncol"},{"key":"5970_CR3","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1002\/cncr.25188","volume":"116","author":"JA Ajani","year":"2010","unstructured":"Ajani JA, Winter KA, Gunderson LL, et al. Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer. 2010;116:4007\u201313.","journal-title":"Cancer"},{"key":"5970_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/DCR.0b013e31819eb7f0","volume":"52","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis Colon Rectum. 2009;52:624\u201331.","journal-title":"Dis Colon Rectum"},{"key":"5970_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/bjs.1800810405","volume":"81","author":"GT Deans","year":"1994","unstructured":"Deans GT, McAleer JJ, Spence RA. Malignant anal tumors. Br J Surg. 1994;81:500\u20138.","journal-title":"Br J Surg"},{"key":"5970_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/1097-0142(20010701)92:1<77::AID-CNCR1294>3.0.CO;2-P","volume":"92","author":"JP Gerard","year":"2001","unstructured":"Gerard JP, Chapet O, Samiei F, et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer. 2001;92:77\u201384.","journal-title":"Cancer"},{"key":"5970_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.12816\/0006000","volume":"6","author":"SA Salati","year":"2012","unstructured":"Salati SA, Al Kadi A. Anal cancer - a review. Int J Health Sci (Qassim). 2012;6:206\u201330.","journal-title":"Int J Health Sci (Qassim)"},{"key":"5970_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74:824\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5970_CR9","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","volume":"22","author":"M Jones","year":"2015","unstructured":"Jones M, Hruby G, Solomon M, Rutherford N, Martin J. The role of FDG-PET in the initial staging and response assessment of anal Cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22:3574\u201381.","journal-title":"Ann Surg Oncol"},{"key":"5970_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-28860-9","volume-title":"Target volume delineation and field setup: a practical guide for conformal and intensity modulated radiation therapy","author":"NY Lee","year":"2013","unstructured":"Lee NY, Lu JJ. Target volume delineation and field setup: a practical guide for conformal and intensity modulated radiation therapy. Berlin, Heidelberg: Springer; 2013."},{"key":"5970_CR11","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S, et al. Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1455\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5970_CR12","unstructured":"Muirhead R, Adams RA, Gilbert DC, Harrison M, Glynne-Jones R, Sebag-Montefiore D, Hawkins MA. NATIONAL GUIDANCE FOR IMRT IN ANAL NATIONAL GUIDANCE FOR IMRT IN ANAL CANCER: the CRUK\/MRC oxford institute for radiation oncology, Oxford; School of Medicine, Cardiff University, Cardiff; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton; Mount Vernon Hospital, Northwood; University of Leeds, St James Institute of Oncology, Leeds; 2016. \n                              http:\/\/analimrtguidance.co.uk\/national-anal-imrt-guidance-v3.pdf\n                              \n                           . Accessed 8 Aug 2018."},{"key":"5970_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13014-018-0977-2","volume":"13","author":"K Schiller","year":"2018","unstructured":"Schiller K, Devecka M, Maurer T, et al. Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer. Radiat Oncol. 2018;13:36.","journal-title":"Radiat Oncol"},{"key":"5970_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1097\/MNM.0000000000000560","volume":"37","author":"AR Teagle","year":"2016","unstructured":"Teagle AR, Gilbert DC, Jones JR, Burkill GJ, McKinna F, Dizdarevic S. Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer. Nucl Med Commun. 2016;37:1038\u201345.","journal-title":"Nucl Med Commun"},{"key":"5970_CR15","unstructured":"Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. Chichester, Hoboken: Wiley; 2017."},{"key":"5970_CR16","volume-title":"Duale Reihe - Anatomie","author":"G Aum\u00fcller","year":"2007","unstructured":"Aum\u00fcller G, Wolff W. Duale Reihe - Anatomie. 1st ed. Stuttgart: Thieme; 2007.","edition":"1"},{"key":"5970_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.6004\/jnccn.2010.0007","volume":"8","author":"PF Engstrom","year":"2010","unstructured":"Engstrom PF, Arnoletti JP, Benson AB, et al. NCCN clinical practice guidelines in oncology. Anal carcinoma. J Natl Compr Cancer Netw. 2010;8:106\u201320.","journal-title":"J Natl Compr Cancer Netw"},{"key":"5970_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.6004\/jnccn.2010.0008","volume":"8","author":"JM Pepek","year":"2010","unstructured":"Pepek JM, Willett CG, Czito BG. Radiation therapy advances for treatment of anal cancer. J Natl Compr Cancer Netw. 2010;8:123\u20139.","journal-title":"J Natl Compr Cancer Netw"},{"key":"5970_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ijrobp.2008.11.021","volume":"75","author":"JC Hodges","year":"2009","unstructured":"Hodges JC, Das P, Eng C, et al. Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with Para-aortic nodal involvement. Int J Radiat Oncol Biol Phys. 2009;75:791\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5970_CR20","doi-asserted-by":"crossref","unstructured":"Dapper H, Habl G, Hirche C, et al. Dosimetric quantification of the incidental irradiation of the 'true' (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines. Acta Oncol. 2018:1\u20136.","DOI":"10.1080\/0284186X.2017.1415459"},{"key":"5970_CR21","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1245\/s10434-010-1010-7","volume":"17","author":"C Hirche","year":"2010","unstructured":"Hirche C, Dresel S, Krempien R, H\u00fcnerbein M. Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience. Ann Surg Oncol. 2010;17:2357\u201362.","journal-title":"Ann Surg Oncol"},{"key":"5970_CR22","volume-title":"Hals und innere Organe","author":"M Sch\u00fcnke","year":"2005","unstructured":"Sch\u00fcnke M, Schulte E, Schumacher U, Voll M, Wesker K. Hals und innere Organe. Stuttgart: Thieme; 2005."},{"key":"5970_CR23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","volume":"68","author":"P Das","year":"2007","unstructured":"Das P, Bhatia S, Eng C, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007;68:794\u2013800.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5970_CR24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","volume":"78","author":"JL Wright","year":"2010","unstructured":"Wright JL, Patil SM, Temple LKF, Minsky BD, Saltz LB, Goodman KA. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. Int J Radiat Oncol Biol Phys. 2010;78:1064\u201372.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5970_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3109\/0284186X.2015.1124141","volume":"55","author":"NB Tomasoa","year":"2016","unstructured":"Tomasoa NB, Meulendijks D, Nijkamp J, Cats A, Dewit L. Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal. Acta Oncol. 2016;55:760\u20136.","journal-title":"Acta Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5970-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:13:04Z","timestamp":1595891584000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5970-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5970"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5970-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethics standards at the Technical University of Munich (TUM) (ethical vote: 385\/18\u2009s).Name of committee: Ethikkommission der Technischen Universit\u00e4t M\u00fcnchen.Due to BayKrG: Art. 27 (Paragraph\u00a04), the IRB has found that consent to participate in this unpersonalized retrospective analysis was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"742"}}